BFO
DXCM icon

Boston Family Office’s DexCom DXCM Stock Holding History

Boston Family Office’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,462
Closed -$203K – 269
2024
Q1 		$203K Buy
+1,462
New +$184K 0.01% 256
2023
Q3 		– Sell
-1,596
Closed -$206K – 257
2023
Q2 		$206K Buy
+1,596
New +$193K 0.02% 248

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Family Office's DXCM Position: Q2 2024 in Review

Boston Family Office sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,462 shares — an estimated $203K sold.

Boston Family Office first reported a position in DXCM in Q2 2023 and held it in 2 quarters. The position peaked at $206K in Q2 2023. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Boston Family Office reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Boston Family Office sold 1,462 DexCom shares in Q2 2024, an estimated $203K.
  • Boston Family Office first reported a position in DexCom in Q2 2023 and held it in 2 quarters.
  • Boston Family Office's DexCom position peaked at $206K in Q2 2023.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Boston Family Office's 13F filing for Q2 2024, filed 12 Aug 2024.